Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Longitudinal Comparison of Aripiprazole vs. Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI

NCT01739127 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT01739127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01739127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Longitudinal Comparison of Aripiprazole vs. Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
February 29, 2016
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, metabolic syndrome x, psychotic disorders